TORNA ALLA VERSIONE GRAFICA

INVESTINTUSCANY - Sito ufficiale


INTESTAZIONE GRAFICA (CANALE)

CONTENUTI

Artificial Heart Developed by the Institute of Clinical Physiology of the CNR

news22/03/07 - Artificial Heart Developed by the Institute of Clinical Physiology of the CNR (Italian National Research Centre) in Pisa and Manufactured by NewCorTec.

NewCorTec announces the beginning of the clinical experimentation of its BestBeat® VAD. The artificial heart has been implanted for the first time in a German patient in Bad Oeynhausen at the well-known Herz - und Diabeteszentrum Cardiosurgical Centre of the University of Bochum in the Ruhr region.
For the first time, the artificial heart developed by the Institute of Clinical Physiology of the Italian National Research Centre (CNR) and manufactured by NewCorTec has been implanted in a German patient at Bochum University. BestBeat, the name of the artificial heart, now beats in a 68-year-old German patient who had been suffering from serious heart decompensation. The patient underwent surgery in the Cardio-surgical Centre of the University of Bochum in Bad Oeynhausen. The operation "is the starting point of clinical experimentation of the Italian 'artificial heart'" said Luigi Donato, 'father' of the device and Director of the Institute of Clinical Physiology of the CNR of Pisa and Chairman of NewCorTec. Experimentation, he added, "will continue over the next few months with other implants in France and in Italian centres, pending authorisation by the Italian Ministry of Heath".
Experimentation will last for about a year and other Italian artificial hearts will be implanted in a French centre and in four Italian centres (Ospedali Riuniti of Bergamo, the Cardio-surgical Centre of CNR in Massa, the Niguarda Hospital in Milan and the Policlinico San Matteo in Pavia). Once experimentation is over by spring 2008, the company hopes to obtain European certification for the device (EC mark).

Press release: http://www.newcortec.com/pressreleases/newcortec070322.pdf


Source: ANSA

 

Docs